Eli Lilly Sues Peptide Vendor

Maybe the pharma suppliers will go a step too far and have the entire situation involving pricing and availability blow up in their face. As long as GLP-1 peptides remain a drug that stands to improve the lives of many people excepting the fact that they are priced out of reach for 95% of the people alongside the supply issues, this could result in a massive PR loss to the extent that we can collectively pressure our government representatives to step in and make proven price gouging a legitimate reason to approve compounding. These companies need to be looked on with the same level of public disdain as Pharma Bro as they are not operating differently.
 
Back
Top